Munro Partners Sells 5,155 Shares of Astera Labs, Inc. $ALAB

Munro Partners decreased its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 11.6% during the fourth quarter, HoldingsChannel.com reports. The firm owned 39,430 shares of the company’s stock after selling 5,155 shares during the period. Munro Partners’ holdings in Astera Labs were worth $6,560,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the stock. Lido Advisors LLC raised its holdings in shares of Astera Labs by 0.5% in the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after acquiring an additional 57 shares in the last quarter. Perigon Wealth Management LLC raised its holdings in shares of Astera Labs by 6.2% during the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock valued at $208,000 after buying an additional 73 shares in the last quarter. Clearstead Advisors LLC raised its holdings in shares of Astera Labs by 13.6% during the 3rd quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock valued at $125,000 after buying an additional 76 shares in the last quarter. Sound Income Strategies LLC increased its stake in Astera Labs by 9.2% in the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after purchasing an additional 76 shares during the period. Finally, Venturi Wealth Management LLC increased its stake in Astera Labs by 2.6% in the 4th quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock worth $546,000 after purchasing an additional 84 shares during the period. Institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $389.20 on Tuesday. The stock has a 50-day simple moving average of $242.61 and a two-hundred day simple moving average of $180.88. Astera Labs, Inc. has a 52-week low of $84.78 and a 52-week high of $398.13. The firm has a market capitalization of $66.71 billion, a PE ratio of 262.97, a P/E/G ratio of 4.86 and a beta of 3.94.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business’s quarterly revenue was up 93.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Insider Activity at Astera Labs

In related news, Director Manuel Alba sold 183,000 shares of the stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the completion of the transaction, the director directly owned 319,863 shares of the company’s stock, valued at approximately $34,420,457.43. This represents a 36.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the sale, the chief operating officer owned 5,064,213 shares in the company, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 2,161,256 shares of company stock valued at $459,844,296. Insiders own 10.40% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on ALAB shares. Northland Securities cut Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Rothschild & Co Redburn assumed coverage on Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective on the stock. Royal Bank Of Canada lifted their price target on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, May 6th. Loop Capital initiated coverage on Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 price target on the stock. Finally, Roth Mkm reiterated a “buy” rating and set a $275.00 price objective on shares of Astera Labs in a research note on Wednesday, May 6th. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.